MarketLens
Sign Up
Stock AnalysisInvestment Ideas

Adicet Bio: A 400% Upside Bet on Gamma Delta T-Cell Data

2 months ago
SHARE THIS ON:

Adicet Bio: A 400% Upside Bet on Gamma Delta T-Cell Data

Exclusive Content for Pro Members

Pro members only. Upgrade to access this article, premium analysis, and stock recommendations.

SHARE THIS ON:

Related Articles

What Does the 400 Gbps/lane Breakthrough Mean for Data Centers

What Does the 400 Gbps/lane Breakthrough Mean for Data Centers

6 months ago
What Makes Tethis' SmartBioSurface® a Game-Changer in Cell Analysis

What Makes Tethis' SmartBioSurface® a Game-Changer in Cell Analysis

4 months ago
Braveheart Bio's Insider Buys At $18 Suggest Undervalued M&A Upside Beyond Initial Pop

Braveheart Bio's Insider Buys At $18 Suggest Undervalued M&A Upside Beyond Initial Pop

2 months ago
Alibaba's AI Bet: Why the Market is Missing a 58% Upside

Alibaba's AI Bet: Why the Market is Missing a 58% Upside

2 months ago

Category

TopFeaturedPro OnlyStock AnalysisInvestment IdeasETFsCrypto

You may also like

Stock News•3 weeks ago

SL Science: A $1.15 Billion Valuation Built On Preclinical Promises

SL Science Holding Limited was rated Sell with a $1.15B valuation, as its preclinical Gamma Delta T cell therapy has not entered human trials. With $9M cash and a $3.82M annual loss, going-concern dou...
SLBT
Stock News•1 months ago

Alpha Tau: Approaching Massive Year-End; Pounding The Table On Potential GBM Breakthrough

Alpha Tau approaches a potential inflection point as GBM data is expected before year-end, after two of the first three patients achieved complete responses. Pancreatic data follows shortly, which cou...
DRTS
Stock News•1 months ago

Adicet Bio: A Cheap Gamma Delta T-Cell Play

Adicet Bio's prula-cel showed a 50% complete renal response in early lupus nephritis data with clean safety, supporting its allogeneic gamma delta CAR-T platform. A pivotal 22-patient readout in 3Q 20...
CAR

Breaking News

View All →
ETFs
AI Chip Demand
Biotech & Pharma
Event-Driven Investing
Expense Ratios
Financial Stocks
Gold & Precious Metals
Healthcare
Management Changes
Pharmaceuticals

Featured Articles

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

DoorDash (DASH): Founder Selling Signals Liquidity, Not Lack of Confidence Amid Robust Growth

2 months ago
Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

Sea Limited's Growth Momentum Outweighs COO's Programmed De-risking

2 months ago
Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

Arista Networks' AI Momentum Encounters Founder's Planned Profit-Taking

2 months ago

Top Headlines

View More →
Stock News•2 hours ago

Amazon plans $7 billion acquisition of Decart, a fast-growing AI startup

Stock News•3 hours ago

Amazon in Talks to Buy AI Startup Decart for Around $7 Billion

Stock News•4 hours ago

ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Alphabet Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - GOOGL, GOOG

Stock News•6 hours ago

Amazon and Alphabet Just Committed $420 Billion to Data Centers. 1 Stock Is the Better Buy.

Stock News•6 hours ago

3 Quantum Computing Stocks Poised to Outperform IonQ and Rigetti This Month